Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Acq. announced
Quarterly results
ONCOSEC MEDICAL Inc (ONCS) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/02/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/18/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "COMMON STOCK PURCHASE WARRANT ONCOSEC MEDICAL INCORPORATED Warrant Shares: _______ Issue Date: __________, 2023 Initial Exercise Date: _____________, 2023 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on _______ [1] but not thereafter, to subscribe for and purchase from OncoSec Medical Incorporated, a Nevada corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwi...",
"PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT ONCOSEC MEDICAL INCORPORATED Warrant Shares: _______ Issue Date: May 18, 2023 Initial Exercise Date: May 18, 2023 THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on May 16, 2028 but not thereafter, to subscribe for and purchase from OncoSec Medical Incorporated, a Nevada corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant is being issued pursuant to t...",
"Letter re: Registration Statement on Form S-3",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of May 16, 2023, between OncoSec Medical Incorporated, a Nevada corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , as to the Shares, the Prefunded Warrants and Prefunded Warrant Shares and an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4 thereof and/or Regulation D promulgated thereunder as to the Common Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as mo...",
"Investor Contact",
"Investor Contact"
05/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact"
04/27/2023 8-K Quarterly results
04/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact"
02/22/2023 8-K Other Events  Interactive Data
01/04/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
12/28/2022 8-K Quarterly results
12/27/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/01/2022 8-K Quarterly results
11/29/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "ONCOSEC MEDICAL INCORPORATED Convertible Promissory Note and Security Agreement due November 25, 2024 Dated: November 25, 2022 $2,000,000.00 For value received, ONCOSEC MEDICAL INCORPORATED, a Nevada corporation , hereby promises to pay to the order of Grand Decade Developments Limited, a British Virgin Islands limited company and a wholly owned subsidiary of Grand Pharmaceutical Group Limited , in accordance with the terms hereinafter provided, the principal amount of $2 million together with interest thereon. All payments under or pursuant to this Note or the other Transaction Documents shall be made in United States Dollars in immediately available funds by wire transfer of funds to the Holder’ s account, instructions for which are set forth on Exhibit A . The outstanding principal bal..."
11/22/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
11/15/2022 8-K Quarterly results
11/14/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact"
11/08/2022 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Investor Contact"
10/17/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/11/2022 8-K Appointed a new director
10/04/2022 8-K Cost Associated with Exit or Disposal Activities, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact"
10/03/2022 8-K Quarterly results
07/12/2022 8-K Quarterly results
06/09/2022 8-K Quarterly results
06/03/2022 8-K Quarterly results
04/29/2022 8-K Quarterly results
02/22/2022 8-K Quarterly results
02/14/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
12/17/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT TO THE AMENDED AND RESTATED BYLAWS OF ONCOSEC MEDICAL INCORPORATED THIS AMENDMENT TO THE BYLAWS OF ONCOSEC MEDICAL INCORPORATED is made effective as of December 15, 2021 , and amends the amended and restated bylaws of OncoSec Medical Incorporated, a Nevada corporation . WHEREAS, pursuant to Article 10 of the Bylaws, the Bylaws may be amended, altered, or repealed and new Bylaws may be adopted at any meeting of the Board of Directors by the affirmative vote of the majority of the whole number of directors. WHEREAS, the Board desires to amend the Bylaws in accordance with the terms and conditions set forth herein. 1. Amendment to Article 3 Section 3.1 . Section 3.1 of Article 3 of the Bylaws is amended and restated in its entirety as follows: “The number of directors of the Corpora...",
"AMENDED AND RESTATED BYLAWS OF ONCOSEC MEDICAL INCORPORATED"
12/09/2021 8-K Quarterly results
11/30/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/15/2021 8-K Regulation FD Disclosure
08/16/2021 8-K Quarterly results
06/24/2021 8-K Quarterly results
04/29/2021 8-K Quarterly results
02/04/2021 8-K Quarterly results
01/21/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Underwriting Agreement, between OncoSec Medical Incorporated and BTIG, LLC, as representative of the several underwriters named therein",
"Opinion of Alston & Bird LLP"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy